Iovance Biotherapeutics Inc (IOVA) — Long-term Investment Intensity
Iovance Biotherapeutics Inc (IOVA) has a Long-term Investment Intensity of 4.0% as of March 2022. Long-term investments of $27.70 Million represent 4.0% of total assets of $701.25 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of Iovance Biotherapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Iovance Biotherapeutics Inc Long-term Investment Intensity (2021–2021)
This chart shows how Iovance Biotherapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of March 2022, the intensity stands at 4.0%, reflecting long-term investments of $27.70 Million against total assets of $701.25 Million USD. Explore cash flow to debt ratio of Iovance Biotherapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Iovance Biotherapeutics Inc (2021–2021)
The table below presents the year-by-year Long-term Investment Intensity for Iovance Biotherapeutics Inc from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Iovance Biotherapeutics Inc worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 11.8% | $91.59 Million | $777.33 Million | — |